Drug Combo Offers Hope Against Advanced Bladder Cancer
THURSDAY, May 14, 2020 (HealthDay News) — A combination of chemotherapy and immunotherapy may slow the progress of metastatic bladder cancer and extend survival, a clinical trial suggests. Current treatment for advanced bladder cancer is chemotherapy, but adding the immunotherapy drug atezolizumab (Tecentriq) appears to help more patients fight thisContinue Reading